ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma.

Rachel A Burga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.